COVID-19 Disruptions Could Lead To Sharp Slowdown In India Pharma Market

An early assessment of the impact of COVID-19 on the Indian pharmaceutical market by IQVIA suggests a significant tapering of growth in 2020, along the lines of similar expectations in some other Asian nations. Some industry experts are endorsing the strained outlook, at least for now.

India
Indian Pharma Market May See Decline In Growth in 2020 • Source: Shutterstock

The Indian pharmaceutical market could witness a sharp deceleration in growth in 2020 amid COVID-19 related disruptions, along the lines of similar declines anticipated in some other Asian nations, an early assessment of the situation by IQVIA has suggested.

The IQVIA study estimates that growth in the Indian pharmaceutical market could slide to 1-5% in 2020 from earlier predictions...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip